STOCK TITAN

LGND (NASDAQ) Form 144: Insider resale via Morgan Stanley, $2.74M listed

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

LGND reported a proposed sale of common stock on a Form 144 with transactions dated 03/04/2026. The filing lists an $2,741,513.52 figure and the number 19,941,141 in the header. The excerpt shows planned sales tied to an exercise of stock options of 2,073 shares on 03/04/2026 and Restricted & Performance Stock Units of 11,350 shares with an award date of 12/31/2025. The sales are shown as common stock to be sold through Morgan Stanley Smith Barney LLC.

Positive

  • None.

Negative

  • None.

Insights

Routine Form 144 lists planned insider resale quantities and an aggregate value.

The filing lists a proposed sale of common stock via broker-dealer Morgan Stanley Smith Barney LLC with an aggregate figure of $2,741,513.52 and header number 19,941,141. Specific instruments include an exercise of stock options for 2,073 shares (dated 03/04/2026) and 11,350 restricted and performance stock units (dated 12/31/2025).

Timing and exact proceeds recipients are limited to the excerpt; execution mechanics and final sold amounts depend on broker and holder decisions. Subsequent filings or transaction reports will show completed sale quantities and proceeds.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does LGND's Form 144 dated 03/04/2026 report?

The form reports a proposed sale of common stock with transactions dated 03/04/2026. It shows an aggregate figure of $2,741,513.52 and lists specific lots of 2,073 and 11,350 shares tied to options and RSUs.

Who is handling the proposed LGND stock sales?

The excerpt lists Morgan Stanley Smith Barney LLC as the broker-dealer handling the transactions. The filing identifies sales of common stock through that firm with transaction dates in the excerpt.

How many shares from option exercise and RSUs are included in LGND's filing?

The filing shows an exercise of stock options for 2,073 shares (dated 03/04/2026) and 11,350 restricted & performance stock units (dated 12/31/2025), as listed in the excerpt.

Does LGND's Form 144 show final sale proceeds received by the company?

No final proceeds recipient is specified in the excerpt. The form lists an aggregate figure of $2,741,513.52, but the excerpt does not state whether proceeds go to the issuer or selling holders.
Ligand Pharma

NASDAQ:LGND

LGND Rankings

LGND Latest News

LGND Latest SEC Filings

LGND Stock Data

4.11B
19.18M
Biotechnology
Pharmaceutical Preparations
Link
United States
SAN DIEGO